PMC:7696151 / 69991-70330
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2028 | 283-288 | Gene | denotes | IFN-α | Gene:111654 |
| 2030 | 30-36 | Species | denotes | murine | Tax:10090 |
| 2037 | 64-67 | Chemical | denotes | HCQ | MESH:D006886 |
| 2046 | 46-51 | Disease | denotes | lupus | MESH:D008180 |
| 2047 | 320-325 | Disease | denotes | lupus | MESH:D008180 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T446 | 0-339 | Sentence | denotes | In vivo studies on a NZB/W F1 murine model of lupus showed that HCQ in combination with PRD (2.5 mg/kg/day and 1 mg/kg/day p.o.) decreased autoantibody production, as well as being able to inhibit toll-like receptor activation, resulting in the down-regulation of type I interferon (IFN-α) which is deeply implicated in lupus pathogenesis. |